Stryker
(NYSE: SYK)
announced today that it completed its previously announced acquisition of joint replacement company SERF SAS.
In December, the Kalamazoo, Michigan-based orthopedic giant struck a deal to buy the France-based company from Menix.
SERF SAS develops, manufactures and sells a range of large joint replacement products on an international basis. This includes inventing the original Dual Mobility Cup for hip replacement. SERF SAS has its main office in Décines-Charpieu, France.
“The acquisition of SERF SAS further strengthens our global portfolio and reinforces our dedication to orthopaedic excellence,” said Katherine Truppi, president of Stryker’s Joint Replacement division. “We welcome the SERF SAS team to Stryker and look forward to working together to help advance product innovation and customer satisfaction.”
SERF SAS complements Stryker’s existing presence in France and across Europe, the company said. It also enhances Stryker’s global joint replacement portfolio. The company said SERF SAS allows it to serve a wider range of patients with a strengthened implant product line.
“The SERF SAS product portfolio is built on a trusted legacy within the orthopaedic industry. We are thrilled to combine our best-in-class product portfolios and work together to expand our presence within Europe and increase patient access to differentiated products for joint replacement,” added said Mathieu Badard, VP and GM of Stryker’s Joint Replacement division in Europe.